10-Q
Quarterly Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
34 line items · 2 periods
XBRL
| Item | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 898,000 | 1,701,000 |
Cash and Cash Equivalents | 1,349,000 | 2,276,000 |
Fair Value, Inputs, Level 1 | 1,349,000 | 2,276,000 |
Other Non-Operating Current Assets | 19,000 | — |
Other Non-Operating Current Assets | 318,000 | 199,000 |
Total current assets | 2,584,000 | 4,176,000 |
Property, Plant and Equipment | 98,000 | 108,000 |
Operating Lease Right-of-Use Asset | 554,000 | 618,000 |
Intangible Assets | 2,267,000 | 2,594,000 |
Patents | 2,173,000 | 2,495,000 |
Trademarks | 94,000 | 99,000 |
Other Non-Operating Non-Current Assets | 745,000 | 1,112,000 |
Total assets | 6,248,000 | 8,608,000 |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
Current liabilities: | ||
Accounts Payable | 6,944,000 | 6,383,000 |
Other Current Liabilities | 639,000 | 606,000 |
Operating Lease Liability, Current | 234,000 | 239,000 |
Short-Term Debt | 1,950,000 | 2,307,000 |
Total current liabilities | 9,767,000 | 9,535,000 |
Long-term liabilities: | ||
Operating Lease Liability, Non-Current | 338,000 | 395,000 |
Total liabilities | 10,105,000 | 9,930,000 |
Stockholders’ deficit: | ||
Total Stockholders' Equity | 72,000 | 66,000 |
Total Stockholders' Equity | 426,604,000 | 425,440,000 |
Total Stockholders' Equity | (430,533,000) | (426,828,000) |
Total stockholders’ deficit | (3,857,000) | (1,322,000) |
Common Stock | 72,000 | 66,000 |
Additional Paid-in Capital | 426,604,000 | 425,440,000 |
Retained Earnings | (430,533,000) | (426,828,000) |
Total liabilities and stockholders’ deficit | 6,248,000 | 8,608,000 |